This Pennsylvania House resolution designates the week of September 20 through 26, 2026, as "Surgical Technologist Week" to recognize the contributions of surgical technologists in the state. The measure directly affects surgical technologists working in hospitals and surgical centers by formally acknowledging their vital role in patient care. It does not create new laws or funding but serves as a symbolic gesture to honor these healthcare professionals, following a similar national observance.
This bill designates November 2026 as Pancreatic Cancer Awareness Month within the state of Pennsylvania. It aims to increase public understanding of the disease by encouraging educational programs and support initiatives for those affected. The resolution does not change laws or allocate funding but serves as a formal statement to highlight the importance of early detection and research.
This Pennsylvania House Resolution designates September 2026 as "ITP Awareness Month" to highlight Immune thrombocytopenia, a rare autoimmune condition that lowers platelet counts and increases bleeding risks. The bill aims to encourage research and support for the more than 50,000 people in the United States living with the disease, which affects women aged 30 to 60 more frequently than others. By officially recognizing the month, the resolution seeks to educate the public about the challenges of diagnosing and managing ITP, which often requires specialized medical treatments like blood transfusions or spleen removal. This measure does not change laws or allocate funding but serves as a symbolic gesture to raise visibility for patients and their families.
This Pennsylvania House Resolution officially designates September 2026 as Thyroid Cancer Awareness Month within the state. The bill does not create new laws, allocate funding, or change existing regulations; instead, it serves as a symbolic gesture to highlight the importance of thyroid health. By recognizing this specific month, the resolution aims to encourage public awareness and education regarding thyroid conditions and cancer prevention.
HB 928 amends Pennsylvania law to expand access to epinephrine auto-injectors for severe allergic reactions. It adds schools, sports organizations, and other public venues to the list of "authorized entities" allowed to store these devices and train staff. The bill clarifies who can access the injectors during emergencies and specifies training requirements for personnel. This directly affects schools, youth programs, and public facilities serving individuals at risk of anaphylaxis.
This bill creates a new tax credit for small businesses in Pennsylvania that help employees pay for health insurance purchased through the state exchange. To qualify, a business must have 50 or fewer employees and make contributions toward health reimbursement arrangements for their workers. The credit is calculated based on the first $1,000 of contributions per employee and can be applied to reduce the business's state tax liability. Companies claiming the credit must submit detailed forms to the Department of Revenue listing employee information and insurance provider details.
HB 75 amends Pennsylvania's Osteopathic Medical Practice Act to update the definition of "primary supervising physician" to include medical doctors (MDs) licensed by the State Board of Medicine, alongside osteopathic physicians (DOs). This change allows physician assistants to have either an MD or a DO as their primary supervising physician under a written agreement, expanding oversight options beyond current restrictions. The amendment takes effect 60 days after enactment and does not alter other provisions of the law.
HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
HB 1117 amends Pennsylvania's 1929 Administrative Code to redefine the Department of Drug and Alcohol Programs' responsibilities for addressing substance use disorders. The department must now develop a comprehensive State plan coordinating prevention, treatment, research, and education across all state agencies and local communities - including health, law enforcement, education, and workforce sectors - to avoid duplication. The plan requires annual review and updates, and mandates the department to provide assistance to local governments while collaborating with medical professionals on drug use guidelines. This change formalizes existing coordination efforts under a unified framework, directly affecting state agencies and local entities managing substance use disorder services.
This resolution designates September 2026 as "Newborn Screening Awareness Month" in Pennsylvania to highlight the importance of early health testing for infants. The bill does not alter any laws or change how screening is conducted; instead, it serves as a symbolic gesture to encourage public awareness among parents, healthcare providers, and the community. By recognizing this month, the House of Representatives aims to promote education about newborn screening programs that detect rare but serious conditions.